tiprankstipranks

Eran Broshy Insider Profile

4 Followers
Eran Broshy, Director at Magellan Health, holds 14.36K shares in Certara (Ticker: CERT), holds 70.02K shares in Theravance Biopharma (Ticker: TBPH), holds 9.64K shares in Magellan Health (Ticker: MGLN). Most recently, Eran Broshy Bought ― shares of Certara on Aug 23, 2023 for an estimated value of 79.06K.
tipranks
Eran Broshy

Eran Broshy
Magellan Health (MGLN)
Director

Not Ranked
Eran Broshy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$922K
72.48%
27.52%
A breakdown of Eran Broshy's holdings

Insider Roles

Theravance Biopharma
(TBPH)
Director
Certara
(CERT)
Director
Roles that Eran Broshy holds in companies

Most Profitable Insider Trade

Stock:
Certara
(CERT)
Rating:Informative Buy
Date:Aug 23, 2023 - Today
Return:+10.00%
The most profitable trade made by Eran Broshy

Eran Broshy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MGLN
Magellan Health
May 25, 2018
Uninformative Buy
$916.18K
Certara
Aug 23, 2023
Director
Informative Buy
79.06K
$253.60K
Theravance Biopharma
May 04, 2023
Director
Uninformative Buy
$667.97K
List of latest transactions for each holding click on a transaction to see Eran Broshy's performance on stock

Eran Broshy insider profile FAQ

What is the percentage of profitable transactions made by Eran Broshy?
The percentage of profitable transactions made by Eran Broshy is ―.
    What is the average return per transaction made by Eran Broshy?
    The average return per transaction made by Eran Broshy is ―.
      What stocks does Eran Broshy hold?
      Eran Broshy holds: MGLN, CERT, TBPH stocks.
        What was Eran Broshy’s latest transaction?
        Eran Broshy latest transaction was an Informative Buy of $79.06K.
          What was Eran Broshy's most profitable transaction?
          Eran Broshy’s most profitable transaction was an Informative Buy of CERT stock on August 23, 2023. The return on the trade was 10.00%.
            What is Eran Broshy's role in Magellan Health?
            Eran Broshy's role in Magellan Health is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.